Johnson & Johnson (NYSE:JNJ) has had a rough three months with its share price down 11%. However, stock prices ...

In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $147.77, denoting a +1.93% change from the preceding trading day.

We recently compiled a list of the 12 Most Reliable Dividend Stocks To Buy According to Hedge Funds. In this article, we are ...

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Johnson & Johnson will acquire all outstanding shares of Intra-Cellular Therapies for $132 per share.

Key Insights Given the large stake in the stock by institutions, Johnson & Johnson's stock price might be vulnerable ...

We recently published a list of 10 Best Dividend Kings Stocks to Invest in Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best dividend ...

We came across a bullish thesis on Johnson & Johnson (NYSE:JNJ) on Business Model Mastery Substack by The Antifragile ...

Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...